- Home
- BRBR
BRBR
BellRing Brands Inc.
as 12-18-2024 4:00pm EST
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders, and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | ST. LOUIS |
| Market Cap: | 9.1B | IPO Year: | 2019 |
| Target Price: | $74.31 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.86 | EPS Growth: | 51.22 |
| 52 Week Low/High: | $48.06 - $79.90 | Next Earning Date: | 02-03-2025 |
| Revenue: | $1,996,200,000 | Revenue Growth: | 19.76% |
| Revenue Growth (this year): | 16.62% | Revenue Growth (next year): | 11.43% |
Latest BellRing Brands Inc. News
BRBR Breaking Stock News: Dive into BRBR Ticker-Specific Updates for Smart Investing
Argus Research
a day ago
BRBR: What does Argus have to say about BRBR?
Zacks
2 days ago
BellRing Brands (BRBR) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks
2 days ago
Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?
Insider Monkey
5 days ago
Why BellRing Brands (BRBR) Is the Best Fitness and Gym Stock to Buy Now?
MT Newswires
5 days ago
BofA Securities Adjusts Price Target on BellRing Brands to $92 From $82
Simply Wall St.
7 days ago
Here's Why We Think BellRing Brands (NYSE:BRBR) Might Deserve Your Attention Today
StockStory
7 days ago
Q3 Earnings Outperformers: TreeHouse Foods (NYSE:THS) And The Rest Of The Shelf-Stable Food Stocks
Argus Research
8 days ago
BRBR: What does Argus have to say about BRBR?
Compare BRBR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRBR BellRing Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.